Trading Halt
Open PDF
| Stock | Amplia Therapeutics Ltd (ATX.ASX) |
|---|---|
| Release Time | 19 Mar 2026, 10:57 a.m. |
| Price Sensitive | Yes |
This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA.
The summaries are generated by large language models so please interpret with care.
Amplia Therapeutics Requests Trading Halt
Key Points
- Pending announcement regarding clinical trial results
- Halt to enable assessment of new data and prepare announcement
- Halt to remain until announcement or market open on 23 March 2026
Full Summary
Amplia Therapeutics Limited has requested an immediate trading halt for all of its securities, pending an announcement regarding clinical trial results following a central reading of data. The company has requested the trading halt to enable it to assess the new data and prepare an appropriate announcement in an orderly manner. The trading halt will remain in place until the earlier of the release of the announcement and the commencement of trading on Monday, 23 March 2026. Amplia is not aware of any reason why the trading halt should not be granted or of any other information necessary to inform the market or ASX about the trading halt. The trading halt request was authorized by Amplia's Board of Directors.
Sign in to get more information about the company, including guidance changes and other insights.
Sign In